Precision Diabetes and DirectSens Partner to Launch MetMark™ AHB Test in the U.S.
New research shows alpha-hydroxybutyrate can identify increased type 2 diabetes risk nearly a decade before diagnosis; DirectSens technology enables routine clinical chemistry testing RALEIGH, N.C. and VIENNA, Sept. 23, 2026 /PRNewswire/ -- Precision Diabetes, Inc. (PDI) and DirectSens...